Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-09-26
1993-03-02
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514411, 540456, A61K 3140, A61K 3144, C07D26700
Patent
active
051909502
ABSTRACT:
A method for the modification of treatment of an immuno regulatory disorder or disease with an FK-506-type immunosuppressive macrolide comprising the administration to a mammalian species in need of such modification of an effective amount of a compound of the formula I. ##STR1##
REFERENCES:
patent: 4894366 (1990-01-01), Okuhara et al.
patent: 4929611 (1990-05-01), Okuhara et al.
Tanaka, et al J. Am. Chem. Soc., 1987, 109, 5031-5033.
March, J. Advance Organic Chemistry Third Ed. John Wiley and Sons, New York, 1985, pp. 627 & 1057.
Beattie Thomas R.
Dumont Francis J.
Wyvratt Matthew J.
Caruso Charles M.
Gupta Y. N.
Merck & Co. , Inc.
North Robert J.
Shah Mukund J.
LandOfFree
Antagonists of immunosuppressive macrolides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of immunosuppressive macrolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of immunosuppressive macrolides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-126762